Unique identity
A product-linked NFC identity designed for one-tap verification.
Investigational research peptide
Retatrutide
Investigational triple-receptor agonist engaging GIP, GLP-1 and glucagon pathways.
Explore presentation-specific analytical records covering identity, purity, measured peptide content, lot traceability and downloadable Certificates of Analysis.
Certified presentations
Selected record10 mg
Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.
Product authentication
Authenticity, built into every product.
Powered by NFC. Secured by blockchain. Verified instantly.
Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.
Secure verification
A blockchain-secured record supporting authenticity and traceability.
Batch documentation
Presentation-specific COAs document identity, purity, measured content and lot information.
Product information
Triple-receptor research, documented by batch.
Retatrutide is an investigational single-molecule agonist designed to engage GIP, GLP-1 and glucagon receptor pathways. This page combines its research classification with presentation-specific analytical records supplied for Royal Pharma samples.
Research class
GIP / GLP-1 / glucagon receptor agonistDevelopment status
Investigational compoundReference CAS
2381089-83-2Physical form
White lyophilized powderResearch profile
One molecule. Three receptor pathways.
Retatrutide extends the dual-incretin model by adding glucagon receptor engagement to GIP and GLP-1 activity. It remains investigational, and this receptor profile is presented for research context only.
Glucose-dependent insulinotropic polypeptide receptor
One component of the compound's combined incretin research profile.
Glucagon-like peptide-1 receptor
A second incretin pathway included in the triple-agonist design.
Glucagon receptor
The third receptor pathway distinguishing Retatrutide from dual agonists.
Quality documentation
Certificate of Analysis
Choose a presentation to display the exact analytical record
supplied for that sample.
Select presentation
For laboratory research use only.
The supplied certificates state that the tested peptides are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.